Your browser doesn't support javascript.
loading
A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer.
Xu, Hongchuang; Wang, Yanpu; Zhang, Jingming; Duan, Xiaojiang; Zhang, Ting; Cai, Xuekang; Ha, Hyunsoo; Byun, Youngjoo; Fan, Yan; Yang, Zhi; Wang, Yiguang; Liu, Zhaofei; Yang, Xing.
Afiliação
  • Xu H; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
  • Wang Y; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
  • Zhang J; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
  • Duan X; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
  • Zhang T; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
  • Cai X; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
  • Ha H; College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong, 30019, South Korea.
  • Byun Y; College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong, 30019, South Korea.
  • Fan Y; Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
  • Yang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Wang Y; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Beijing, 100142, China.
  • Liu Z; State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, China.
  • Yang X; Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. liuzf@bjmu.edu.cn.
Eur J Nucl Med Mol Imaging ; 49(8): 2693-2704, 2022 07.
Article em En | MEDLINE | ID: mdl-35235005

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Lutécio Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Lutécio Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article